Naringin Attenuates the Development of Carrageenan-Induced Acute Lung Inflammation Through Inhibition of NF-κb, STAT3 and Pro-Inflammatory Mediators and Enhancement of IκBα and Anti-Inflammatory Cytokines

Naringin has been reported to possess diverse pharmacological properties, including anti-arthritic and anti-inflammatory activities. The aim of the present study was to determine the potential anti-inflammatory effect of naringin in a mouse model of carrageenan-induced pleurisy. A single dose of nar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Inflammation 2015-04, Vol.38 (2), p.846-857
Hauptverfasser: Ahmad, Sheikh Fayaz, Attia, Sabry M., Bakheet, Saleh A., Zoheir, Khairy M. A., Ansari, Mushtaq Ahmad, Korashy, Hesham M., Abdel-Hamied, Hala E., Ashour, Abdelkader E., Abd-Allah, Adel R. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 857
container_issue 2
container_start_page 846
container_title Inflammation
container_volume 38
creator Ahmad, Sheikh Fayaz
Attia, Sabry M.
Bakheet, Saleh A.
Zoheir, Khairy M. A.
Ansari, Mushtaq Ahmad
Korashy, Hesham M.
Abdel-Hamied, Hala E.
Ashour, Abdelkader E.
Abd-Allah, Adel R. A.
description Naringin has been reported to possess diverse pharmacological properties, including anti-arthritic and anti-inflammatory activities. The aim of the present study was to determine the potential anti-inflammatory effect of naringin in a mouse model of carrageenan-induced pleurisy. A single dose of naringin (40 and 80 mg/kg) was administered per oral (p.o.) 1 h before carrageenan (Cg) administration. Pro- and anti-inflammatory cytokines were analysed in pleural fluid. We also assessed the effects of naringin on the expression levels of iNOS, inducible cyclooxygenase isoform (COX-2), ICAM-1, MIP-2, PGE2, STAT3, TGF-β1, nuclear factor kappa B (NF-κB) and inhibitor of kappa B (IκBα) in lung tissue. The histological examinations revealed anti-inflammatory effect of naringin while Cg group deteriorated. Naringin downregulated Th1 and upregulated Th2 cytokines. Western blot analyses revealed increased protein expression of NF-κB, STAT3 and COX-2 and decreased IκBα in response to Cg treatment, which were reversed by the treatment with naringin. In the Cg group, mRNA expression levels of pro-inflammatory mediators upregulated and anti-inflammatory mediators downregulated. Naringin reversed these actions.
doi_str_mv 10.1007/s10753-014-9994-y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1668245884</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1668245884</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-8c3d627ca4c0cf9056bc82a41f0559b402a82bfe9f60ec05d97a80958838c6b63</originalsourceid><addsrcrecordid>eNp9kcFu1DAURS0EokPhA9ggL1lgsJPYsZdhaGGkoUViWEeO8zJJSezBdpDyWWz7EcMvkZlpK3XDytZ7517ZOgi9ZvQ9ozT_EBjNeUooy4hSKiPTE7RgPE9JwnPxFC1oKihJlcrP0IsQbiilUsn0OTpLOGM5F_kC_b3SvrPbzuIiRrCjjhBwbAF_gt_Qu90ANmLX4KX2Xm8BrLZkZevRQI0LM0bA69Fu8co2vR4GHTtn8ab1bty287Dtqu44mhuuLsn-tnqHv2-KTYq1rfE378hD0PkJf4W6O9zCcX1hW20N3L9gtb_9uP9z3BQ2do-Tyym6n52F8BI9a3Qf4NXdeY5-XF5sll_I-vrzalmsickSGok0aS2S3OjMUNMoykVlZKIz1lDOVZXRRMukakA1goKhvFa5llRxKVNpRCXSc_T21Lvz7tcIIZZDFwz0vbbgxlAyIWSSzXw2o-yEGu9C8NCUO98N2k8lo-XBY3nyWM4ey4PHcpozb-7qx2qA-iFxL24GkhMQdgd_4MsbN3o7f_k_rf8AU7eujQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1668245884</pqid></control><display><type>article</type><title>Naringin Attenuates the Development of Carrageenan-Induced Acute Lung Inflammation Through Inhibition of NF-κb, STAT3 and Pro-Inflammatory Mediators and Enhancement of IκBα and Anti-Inflammatory Cytokines</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Ahmad, Sheikh Fayaz ; Attia, Sabry M. ; Bakheet, Saleh A. ; Zoheir, Khairy M. A. ; Ansari, Mushtaq Ahmad ; Korashy, Hesham M. ; Abdel-Hamied, Hala E. ; Ashour, Abdelkader E. ; Abd-Allah, Adel R. A.</creator><creatorcontrib>Ahmad, Sheikh Fayaz ; Attia, Sabry M. ; Bakheet, Saleh A. ; Zoheir, Khairy M. A. ; Ansari, Mushtaq Ahmad ; Korashy, Hesham M. ; Abdel-Hamied, Hala E. ; Ashour, Abdelkader E. ; Abd-Allah, Adel R. A.</creatorcontrib><description>Naringin has been reported to possess diverse pharmacological properties, including anti-arthritic and anti-inflammatory activities. The aim of the present study was to determine the potential anti-inflammatory effect of naringin in a mouse model of carrageenan-induced pleurisy. A single dose of naringin (40 and 80 mg/kg) was administered per oral (p.o.) 1 h before carrageenan (Cg) administration. Pro- and anti-inflammatory cytokines were analysed in pleural fluid. We also assessed the effects of naringin on the expression levels of iNOS, inducible cyclooxygenase isoform (COX-2), ICAM-1, MIP-2, PGE2, STAT3, TGF-β1, nuclear factor kappa B (NF-κB) and inhibitor of kappa B (IκBα) in lung tissue. The histological examinations revealed anti-inflammatory effect of naringin while Cg group deteriorated. Naringin downregulated Th1 and upregulated Th2 cytokines. Western blot analyses revealed increased protein expression of NF-κB, STAT3 and COX-2 and decreased IκBα in response to Cg treatment, which were reversed by the treatment with naringin. In the Cg group, mRNA expression levels of pro-inflammatory mediators upregulated and anti-inflammatory mediators downregulated. Naringin reversed these actions.</description><identifier>ISSN: 0360-3997</identifier><identifier>EISSN: 1573-2576</identifier><identifier>DOI: 10.1007/s10753-014-9994-y</identifier><identifier>PMID: 25117567</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject><![CDATA[Animals ; Anti-Inflammatory Agents - pharmacology ; Anti-Inflammatory Agents - therapeutic use ; Biomedical and Life Sciences ; Biomedicine ; Carrageenan - toxicity ; Cytokines - antagonists & inhibitors ; Cytokines - metabolism ; Dose-Response Relationship, Drug ; Female ; Flavanones - pharmacology ; Flavanones - therapeutic use ; I-kappa B Kinase - antagonists & inhibitors ; I-kappa B Kinase - metabolism ; Immunology ; Inflammation Mediators - antagonists & inhibitors ; Inflammation Mediators - metabolism ; Internal Medicine ; Mice ; Mice, Inbred BALB C ; NF-kappa B - antagonists & inhibitors ; NF-kappa B - metabolism ; Pathology ; Pharmacology/Toxicology ; Pleurisy - metabolism ; Pleurisy - prevention & control ; Rheumatology ; STAT3 Transcription Factor - antagonists & inhibitors ; STAT3 Transcription Factor - metabolism]]></subject><ispartof>Inflammation, 2015-04, Vol.38 (2), p.846-857</ispartof><rights>Springer Science+Business Media New York 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-8c3d627ca4c0cf9056bc82a41f0559b402a82bfe9f60ec05d97a80958838c6b63</citedby><cites>FETCH-LOGICAL-c420t-8c3d627ca4c0cf9056bc82a41f0559b402a82bfe9f60ec05d97a80958838c6b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10753-014-9994-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10753-014-9994-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25117567$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahmad, Sheikh Fayaz</creatorcontrib><creatorcontrib>Attia, Sabry M.</creatorcontrib><creatorcontrib>Bakheet, Saleh A.</creatorcontrib><creatorcontrib>Zoheir, Khairy M. A.</creatorcontrib><creatorcontrib>Ansari, Mushtaq Ahmad</creatorcontrib><creatorcontrib>Korashy, Hesham M.</creatorcontrib><creatorcontrib>Abdel-Hamied, Hala E.</creatorcontrib><creatorcontrib>Ashour, Abdelkader E.</creatorcontrib><creatorcontrib>Abd-Allah, Adel R. A.</creatorcontrib><title>Naringin Attenuates the Development of Carrageenan-Induced Acute Lung Inflammation Through Inhibition of NF-κb, STAT3 and Pro-Inflammatory Mediators and Enhancement of IκBα and Anti-Inflammatory Cytokines</title><title>Inflammation</title><addtitle>Inflammation</addtitle><addtitle>Inflammation</addtitle><description>Naringin has been reported to possess diverse pharmacological properties, including anti-arthritic and anti-inflammatory activities. The aim of the present study was to determine the potential anti-inflammatory effect of naringin in a mouse model of carrageenan-induced pleurisy. A single dose of naringin (40 and 80 mg/kg) was administered per oral (p.o.) 1 h before carrageenan (Cg) administration. Pro- and anti-inflammatory cytokines were analysed in pleural fluid. We also assessed the effects of naringin on the expression levels of iNOS, inducible cyclooxygenase isoform (COX-2), ICAM-1, MIP-2, PGE2, STAT3, TGF-β1, nuclear factor kappa B (NF-κB) and inhibitor of kappa B (IκBα) in lung tissue. The histological examinations revealed anti-inflammatory effect of naringin while Cg group deteriorated. Naringin downregulated Th1 and upregulated Th2 cytokines. Western blot analyses revealed increased protein expression of NF-κB, STAT3 and COX-2 and decreased IκBα in response to Cg treatment, which were reversed by the treatment with naringin. In the Cg group, mRNA expression levels of pro-inflammatory mediators upregulated and anti-inflammatory mediators downregulated. Naringin reversed these actions.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Carrageenan - toxicity</subject><subject>Cytokines - antagonists &amp; inhibitors</subject><subject>Cytokines - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Flavanones - pharmacology</subject><subject>Flavanones - therapeutic use</subject><subject>I-kappa B Kinase - antagonists &amp; inhibitors</subject><subject>I-kappa B Kinase - metabolism</subject><subject>Immunology</subject><subject>Inflammation Mediators - antagonists &amp; inhibitors</subject><subject>Inflammation Mediators - metabolism</subject><subject>Internal Medicine</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>NF-kappa B - antagonists &amp; inhibitors</subject><subject>NF-kappa B - metabolism</subject><subject>Pathology</subject><subject>Pharmacology/Toxicology</subject><subject>Pleurisy - metabolism</subject><subject>Pleurisy - prevention &amp; control</subject><subject>Rheumatology</subject><subject>STAT3 Transcription Factor - antagonists &amp; inhibitors</subject><subject>STAT3 Transcription Factor - metabolism</subject><issn>0360-3997</issn><issn>1573-2576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1DAURS0EokPhA9ggL1lgsJPYsZdhaGGkoUViWEeO8zJJSezBdpDyWWz7EcMvkZlpK3XDytZ7517ZOgi9ZvQ9ozT_EBjNeUooy4hSKiPTE7RgPE9JwnPxFC1oKihJlcrP0IsQbiilUsn0OTpLOGM5F_kC_b3SvrPbzuIiRrCjjhBwbAF_gt_Qu90ANmLX4KX2Xm8BrLZkZevRQI0LM0bA69Fu8co2vR4GHTtn8ab1bty287Dtqu44mhuuLsn-tnqHv2-KTYq1rfE378hD0PkJf4W6O9zCcX1hW20N3L9gtb_9uP9z3BQ2do-Tyym6n52F8BI9a3Qf4NXdeY5-XF5sll_I-vrzalmsickSGok0aS2S3OjMUNMoykVlZKIz1lDOVZXRRMukakA1goKhvFa5llRxKVNpRCXSc_T21Lvz7tcIIZZDFwz0vbbgxlAyIWSSzXw2o-yEGu9C8NCUO98N2k8lo-XBY3nyWM4ey4PHcpozb-7qx2qA-iFxL24GkhMQdgd_4MsbN3o7f_k_rf8AU7eujQ</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Ahmad, Sheikh Fayaz</creator><creator>Attia, Sabry M.</creator><creator>Bakheet, Saleh A.</creator><creator>Zoheir, Khairy M. A.</creator><creator>Ansari, Mushtaq Ahmad</creator><creator>Korashy, Hesham M.</creator><creator>Abdel-Hamied, Hala E.</creator><creator>Ashour, Abdelkader E.</creator><creator>Abd-Allah, Adel R. A.</creator><general>Springer US</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20150401</creationdate><title>Naringin Attenuates the Development of Carrageenan-Induced Acute Lung Inflammation Through Inhibition of NF-κb, STAT3 and Pro-Inflammatory Mediators and Enhancement of IκBα and Anti-Inflammatory Cytokines</title><author>Ahmad, Sheikh Fayaz ; Attia, Sabry M. ; Bakheet, Saleh A. ; Zoheir, Khairy M. A. ; Ansari, Mushtaq Ahmad ; Korashy, Hesham M. ; Abdel-Hamied, Hala E. ; Ashour, Abdelkader E. ; Abd-Allah, Adel R. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-8c3d627ca4c0cf9056bc82a41f0559b402a82bfe9f60ec05d97a80958838c6b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Carrageenan - toxicity</topic><topic>Cytokines - antagonists &amp; inhibitors</topic><topic>Cytokines - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Flavanones - pharmacology</topic><topic>Flavanones - therapeutic use</topic><topic>I-kappa B Kinase - antagonists &amp; inhibitors</topic><topic>I-kappa B Kinase - metabolism</topic><topic>Immunology</topic><topic>Inflammation Mediators - antagonists &amp; inhibitors</topic><topic>Inflammation Mediators - metabolism</topic><topic>Internal Medicine</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>NF-kappa B - antagonists &amp; inhibitors</topic><topic>NF-kappa B - metabolism</topic><topic>Pathology</topic><topic>Pharmacology/Toxicology</topic><topic>Pleurisy - metabolism</topic><topic>Pleurisy - prevention &amp; control</topic><topic>Rheumatology</topic><topic>STAT3 Transcription Factor - antagonists &amp; inhibitors</topic><topic>STAT3 Transcription Factor - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahmad, Sheikh Fayaz</creatorcontrib><creatorcontrib>Attia, Sabry M.</creatorcontrib><creatorcontrib>Bakheet, Saleh A.</creatorcontrib><creatorcontrib>Zoheir, Khairy M. A.</creatorcontrib><creatorcontrib>Ansari, Mushtaq Ahmad</creatorcontrib><creatorcontrib>Korashy, Hesham M.</creatorcontrib><creatorcontrib>Abdel-Hamied, Hala E.</creatorcontrib><creatorcontrib>Ashour, Abdelkader E.</creatorcontrib><creatorcontrib>Abd-Allah, Adel R. A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Inflammation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahmad, Sheikh Fayaz</au><au>Attia, Sabry M.</au><au>Bakheet, Saleh A.</au><au>Zoheir, Khairy M. A.</au><au>Ansari, Mushtaq Ahmad</au><au>Korashy, Hesham M.</au><au>Abdel-Hamied, Hala E.</au><au>Ashour, Abdelkader E.</au><au>Abd-Allah, Adel R. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Naringin Attenuates the Development of Carrageenan-Induced Acute Lung Inflammation Through Inhibition of NF-κb, STAT3 and Pro-Inflammatory Mediators and Enhancement of IκBα and Anti-Inflammatory Cytokines</atitle><jtitle>Inflammation</jtitle><stitle>Inflammation</stitle><addtitle>Inflammation</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>38</volume><issue>2</issue><spage>846</spage><epage>857</epage><pages>846-857</pages><issn>0360-3997</issn><eissn>1573-2576</eissn><abstract>Naringin has been reported to possess diverse pharmacological properties, including anti-arthritic and anti-inflammatory activities. The aim of the present study was to determine the potential anti-inflammatory effect of naringin in a mouse model of carrageenan-induced pleurisy. A single dose of naringin (40 and 80 mg/kg) was administered per oral (p.o.) 1 h before carrageenan (Cg) administration. Pro- and anti-inflammatory cytokines were analysed in pleural fluid. We also assessed the effects of naringin on the expression levels of iNOS, inducible cyclooxygenase isoform (COX-2), ICAM-1, MIP-2, PGE2, STAT3, TGF-β1, nuclear factor kappa B (NF-κB) and inhibitor of kappa B (IκBα) in lung tissue. The histological examinations revealed anti-inflammatory effect of naringin while Cg group deteriorated. Naringin downregulated Th1 and upregulated Th2 cytokines. Western blot analyses revealed increased protein expression of NF-κB, STAT3 and COX-2 and decreased IκBα in response to Cg treatment, which were reversed by the treatment with naringin. In the Cg group, mRNA expression levels of pro-inflammatory mediators upregulated and anti-inflammatory mediators downregulated. Naringin reversed these actions.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>25117567</pmid><doi>10.1007/s10753-014-9994-y</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0360-3997
ispartof Inflammation, 2015-04, Vol.38 (2), p.846-857
issn 0360-3997
1573-2576
language eng
recordid cdi_proquest_miscellaneous_1668245884
source MEDLINE; SpringerNature Journals
subjects Animals
Anti-Inflammatory Agents - pharmacology
Anti-Inflammatory Agents - therapeutic use
Biomedical and Life Sciences
Biomedicine
Carrageenan - toxicity
Cytokines - antagonists & inhibitors
Cytokines - metabolism
Dose-Response Relationship, Drug
Female
Flavanones - pharmacology
Flavanones - therapeutic use
I-kappa B Kinase - antagonists & inhibitors
I-kappa B Kinase - metabolism
Immunology
Inflammation Mediators - antagonists & inhibitors
Inflammation Mediators - metabolism
Internal Medicine
Mice
Mice, Inbred BALB C
NF-kappa B - antagonists & inhibitors
NF-kappa B - metabolism
Pathology
Pharmacology/Toxicology
Pleurisy - metabolism
Pleurisy - prevention & control
Rheumatology
STAT3 Transcription Factor - antagonists & inhibitors
STAT3 Transcription Factor - metabolism
title Naringin Attenuates the Development of Carrageenan-Induced Acute Lung Inflammation Through Inhibition of NF-κb, STAT3 and Pro-Inflammatory Mediators and Enhancement of IκBα and Anti-Inflammatory Cytokines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A59%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Naringin%20Attenuates%20the%20Development%20of%20Carrageenan-Induced%20Acute%20Lung%20Inflammation%20Through%20Inhibition%20of%20NF-%CE%BAb,%20STAT3%20and%20Pro-Inflammatory%20Mediators%20and%20Enhancement%20of%20I%CE%BAB%CE%B1%20and%20Anti-Inflammatory%20Cytokines&rft.jtitle=Inflammation&rft.au=Ahmad,%20Sheikh%20Fayaz&rft.date=2015-04-01&rft.volume=38&rft.issue=2&rft.spage=846&rft.epage=857&rft.pages=846-857&rft.issn=0360-3997&rft.eissn=1573-2576&rft_id=info:doi/10.1007/s10753-014-9994-y&rft_dat=%3Cproquest_cross%3E1668245884%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1668245884&rft_id=info:pmid/25117567&rfr_iscdi=true